SCHEMBL23716473

SCHEMBL23716473

Cc1ccc(Cc2cc(Br)ccn2)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ KDM5A P29375 2/20 0.35
▸ KDM5B Q9UGL1 2/20 0.35
▸ KDM2B Q8NHM5 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ KMO O15229 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ KDM4A O75164 1/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ KLKB1 P03952 3/20 0.32
▸ MAP4K1 Q92918 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17663978 0.86 TSHR (0.42) CYP3A4KDM5AKDM5BKMT2AALDH1A1
SCHEMBL23716376 0.79 L3MBTL1 (0.36) KDM4EKDM5AKDM5BALDH1A1KDM4A
SCHEMBL17663981 0.79 GPR52 (0.38) CYP3A4KDM5AKDM5BKMOMAPT
SCHEMBL12107538 0.74 CYP3A4 (0.54) CYP3A4KDM4ELMNAALDH1A1NPSR1
SCHEMBL23716203 0.72 MBOAT4 (0.39) CYP3A4KDM4ELMNAALDH1A1NPSR1
SCHEMBL23716445 0.72 KEAP1 (0.38) CYP3A4KDM4ELMNAALDH1A1NPSR1
SCHEMBL12706760 0.69 CYP3A4 (0.48) CYP3A4KDM4ELMNAALDH1A1NPSR1
SCHEMBL12607303 0.68 CYP3A4 (0.77) CYP3A4KDM4EMEN1KMT2AALDH1A1
SCHEMBL168931 0.68 — —
SCHEMBL28233999 0.68 SLC6A2 (0.43) CYP3A4KDM5AKDM5BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209732-B1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS SCRIPPS RESEARCH INST (US) 2021-08-04 — — EP disclosed
Send feedback